Form 4 · Statement of Changes in Beneficial Ownership · Filed 2025-09-26
Feld Michael Files Becton, Dickinson and Company (BDX) Form 4 - September 26, 2025
Feld Michael sold 58 BDX shares worth $10.5K in this Form 4 filing, reported to the SEC on 2025-09-26.
- Insider
- Feld Michael
- Issuer
- Becton, Dickinson and Company BDX · NYSE
- Filed
- Period
- 2025-09-26
- Accession
- 0001628280-25-043134
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Feld Michael | 2025-09-26 | Sell | 58 | $181.03 | $10.5K | Direct |
| Net change | −58 | −$10.5K | ||||
About Becton, Dickinson and Company
Becton, Dickinson and Company, commonly known as BD, is a prominent American multinational corporation engaged in the development and manufacture of a diverse range of medical devices, instrument systems, and reagents. A key player in the healthcare industry, BD focuses on improving medical discovery, diagnostics, and the delivery of care. BD's products are instrumental in supporting healthcare professionals worldwide in enhancing patient safety and reducing the risks associated with healthcare workers. The company operates across three main segments: BD Medical, BD Life Sciences, and BD Interventional, impacting various sectors such as pharmaceuticals, hospital healthcare systems, and clinical laboratories. With a strong commitment to innovation and quality, Becton, Dickinson and Company contributes significantly to advancements in patient care, operating efficiency in medical settings, and is noted for its commitment to addressing healthcare challenges on a global scale. Headquartered in Franklin Lakes, New Jersey, BD maintains a robust presence across numerous countries, underpinning its influential role in the evolution and improvement of global healthcare infrastructure.
Track BDX insider activity
Get alerted when Becton, Dickinson and Company executives buy or sell their shares.